Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants - Summary - MDSpire
Advertisement
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
To analyze trends in hematopoietic stem cell transplantation (HSCT) in Europe, focusing on the use of alternative donors and their implications for future practices.
Key Findings:
A total of 34,809 patients received their first transplant in 2013, with 43% being allogeneic and 57% autologous, indicating a significant patient population.
There was a 3.4% increase in total transplants compared to 2012, with a notable 5.5% increase in allogeneic HSCT, reflecting evolving practices.
The use of haploidentical donors increased, while the number of cord blood transplants decreased, indicating a shift in donor preference.
Interpretation:
The data indicates a shift towards haploidentical donors in HSCT, reflecting changing donor availability and preferences in transplant practices, which may influence future donor selection strategies.
Limitations:
The survey did not adjust for patients crossing borders for transplants, which may affect transplant rate accuracy and the overall understanding of HSCT trends.
Data collection relied on voluntary reporting from centers, which could introduce reporting biases and affect the comprehensiveness of the data.
Conclusion:
The trends observed in the 2013 survey highlight significant changes in donor selection for HSCT in Europe, with implications for future transplant strategies and the need for ongoing research in this area.
by J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J H F Falkenburg, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda, M Mohty
